All News
@rheumnow #ACR19 ABS2594 prospective cohort study of 56 early cutaneous SSc pts found no association between ETAR &AT1R Abs positivity & vascular complications making ETAR &AT1R abs unlikely prognostic markers of Vasc complications #acrbest https://t.co/e9kNSFeBOx
Olga Petryna DrPetryna ( View Tweet)
Some immunodeficiencies present primarily with autoimmune or lymphoproliferative features…hence the need to consider immunodeficiency in patients with suspected rheumatic disease. Dr. Mahta Mortezavi #ACR19 @RheumNow
Jonathan Hausmann MD hausmannMD ( View Tweet)
@DBrandmanMD speaking at #ACR19 on NAFLD:
HOW MUCH WEIGHT LOSS to do you need to improve/reverse stages of #FattyLiver?
>3% for steatosis
>5% for NASH improvement
>7% for NASH resolution
>10% for cirrhosis reversal (only 10% of pts get there)
@RheumNow @ACRheum
Adam Kilian MD KilianMD ( View Tweet)
As recommended by @doctorswade's research, Dr. Mahta Mortezavi recommends checking baseline immunoglobulins prior to rituximab use. #ACR19 @RheumNow https://t.co/EMapSb0tTW
Jonathan Hausmann MD hausmannMD ( View Tweet)
@RheumNow 5T063 Immunodeficiency for the Rheumatologist: immune defects and corresponding clincial features https://t.co/iUvjP6hNdY
Olga Petryna DrPetryna ( View Tweet)
Gut microbiome-altering drugs like steroids, PPIs and antibiotics had negative effect on tumor response when given prior to checkpoint inhibitor therapy abstr#1811 @RheumNow @cappelliMD @LCalabreseDO #acr19 #cleclinicrheum
Cassandra Calabrese CCalabreseDO ( View Tweet)
Dr. Mease discusses the ACR/NPF recommendations for treatment naive PsA pts. This slide details starting with TNFi for patients. #ACRbest #ACR19 @RheumNow https://t.co/0GZ2RFPWjW
Dr. Rachel Tate uptoTate ( View Tweet)
Romo increased BMD across eGFR subgroups vs Pbo. Reduction in new vertebral fractures not affected by eGFR. https://t.co/HMkREcwoQj #ACR19 @RheumNow plenary#2730 #ACRbest https://t.co/9ojwhmmZxx
Dr. Rachel Tate uptoTate ( View Tweet)
Abstr# 2160: Myopenia is associated with risk of rotator cuff tearing in the elderly.
A great reminder to encourage exercise and building muscle mass to our patients. #ACR19 @RheumNow https://t.co/w5WrL6YcD7
Dr. Paul Sufka psufka ( View Tweet)
#ACR19 Poll: When treating PMR, how do you recognize when patients are having a relapse or flare while tapering steroids? @RheumNow
Dr. Paul Sufka psufka ( View Tweet)
Risk of progression of MGUS to myeloma is 1%/yr
#ACR19 @rheumnow 5T064 https://t.co/T0K0cNlW04
Dr Irwin Lim _connectedcare ( View Tweet)
@rheumnow #ACR19 ABS2353 Real-life observ cohort study demonstrates ACPA testing well adopted by US rheum (77.6% tested at Dx) but does not influence treatment choice (Rx w/bDMARD had similar distribution regardless of ACPA status) https://t.co/2V8VqHATJd
Olga Petryna DrPetryna ( View Tweet)
Abstr#2111-symptomatic coccidiomycosis more prevalent in pts using steroids with biologics. Nice retrospective study on this unmet need @RheumNow #ACR19
Cassandra Calabrese CCalabreseDO ( View Tweet)
@RheumNow #ACR19 abs2467 multicenter observational study analysis concludes sleep impairment in PsA is mainly mediated by subjective factors like anxiety and pain rather than inflammation https://t.co/q64dhsZILW
Olga Petryna DrPetryna ( View Tweet)
Nice study reminding us we need to do a better job of screening for chronic hepatitis B prior ritux (and ALL other forms of immunosuppressive) with HBsAg, HBcAb and HBsAb abstr#2100 @RheumNow #ACR19 @LCalabreseDO https://t.co/s7yogf6qC0
Cassandra Calabrese CCalabreseDO ( View Tweet)
COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/V0QNfi33eA #ACR19 @RheumNow plenary#2729 #ACRbest https://t.co/VVkEfLpHzs
Dr. Rachel Tate uptoTate ( View Tweet)
Is there any data about the safety of 8000u of vitamin A daily? Just asking because I have no idea #ACR19 @RheumNow https://t.co/aLtCOgujdK
Philip Robinson philipcrobinson ( View Tweet)
Gout increases risk of fatal & non-fatal CVD events (in pop without previous CVD events)
No obvious protection from using Allopurinol
Population level study
#ACR19 @rheumnow Abst2732 https://t.co/yQu0PjkmIN
Dr Irwin Lim _connectedcare ( View Tweet)
Spending and price trending of bDMARDs. https://t.co/gB6xjvialr #ACR19 @RheumNow plenary#2731 https://t.co/YNpwYvTu1y
Dr. Rachel Tate uptoTate ( View Tweet)
Abstr# 2156: Something I had never heard of — Yao Syndrome.
This is an adult onset (mean 25.9yo at presentation) autoinflammatory syndrome associated with NOD2 mutations. #ACR19 @RheumNow https://t.co/J71t6uqrSx
Dr. Paul Sufka psufka ( View Tweet)